Alcon Unveils Agenda for 2025 Annual General Meeting

Key Takeaways

Alcon’s third in-person Annual General Meeting (AGM) is scheduled for May 6, 2025, in Geneva.
Deborah Di Sanzo is nominated for election to the Board, while current member Raquel C. Bono will not seek re-election.
A proposed gross dividend of CHF 0.28 per share is on the agenda, with the ex-dividend date expected between May 13 and May 14, 2025.

Annual General Meeting Details

Alcon, a leader in eye care, is set to hold its third in-person Annual General Meeting (AGM) on May 6, 2025, in Geneva. The company expresses enthusiasm about the direct interaction with shareholders during this meeting.

Among the key proposals, Alcon’s Board of Directors has nominated Deborah Di Sanzo for election as a new Board member. Di Sanzo has over thirty years of expertise in technology and health care, notably serving as the president of Best Buy Health since 2020, where she focuses on health technology solutions. She also instructs at the Harvard T.H. Chan School of Public Health and has been a board member of AstraZeneca since 2017.

Current Board member Raquel C. Bono, M.D., will not seek re-election after three years serving on the Board. All other Board members are slated for re-election. Mike Ball, Chair of the Alcon Board, expressed gratitude for Dr. Bono’s contributions during her tenure.

Key items on the AGM agenda include:

1. Approval of Alcon Inc.’s annual financial statements for 2024.
2. Discussion on the appropriation of earnings and a proposed dividend of CHF 0.28 per share, expected to be payable from May 15, 2025, following a withholding tax of 35%.
3. Consultative and binding votes related to compensation for the Board and Executive Committee as well as non-financial reports.

The invitation to the AGM will be published in the Swiss Gazette of Commerce on April 4, 2025, and will be accessible with additional materials on Alcon’s investor relations website. Various votes regarding the re-election of Board members, committee members, and independent representatives will also take place.

Alcon continues to reinforce its commitment to enhancing eye care globally, as it operates in over 140 countries, providing innovative solutions for common vision-related conditions. For further updates, interested parties may visit Alcon’s official website.

The content above is a summary. For more details, see the source article.